Abstract:The field of cardiac tissue engineering has advanced over the past decades; however, most research progress has been limited to engineered cardiac tissues (ECTs) at the microscale with minimal geometrical complexities such as 3D strips and patches. Although microscale ECTs are advantageous for drug screening applications because of their high-throughput and standardization characteristics, they have limited translational applications in heart repair and the in vitro modeling of cardiac function and diseases. Recently, researchers have made various attempts to construct engineered cardiac pumps (ECPs) such as chambered ventricles, recapitulating the geometrical complexity of the native heart. The transition from microscale ECTs to ECPs at a translatable scale would greatly accelerate their translational applications; however, researchers are confronted with several major hurdles, including geometrical reconstruction, vascularization, and functional maturation. Therefore, the objective of this paper is to review the recent advances on bioengineering approaches for fabrication of functional engineered cardiac pumps. We first review the bioengineering approaches to fabricate ECPs, and then emphasize the unmatched potential of 3D bioprinting techniques. We highlight key advances in bioprinting strategies with high cell density as researchers have begun to realize the critical role that the cell density of non-proliferative cardiomyocytes plays in the cell-cell interaction and functional contracting performance. We summarize the current approaches to engineering vasculatures both at micro- and meso-scales, crucial for the survival of thick cardiac tissues and ECPs. We showcase a variety of strategies developed to enable the functional maturation of cardiac tissues, mimicking the in vivo environment during cardiac development. By highlighting state-of-the-art research, this review offers personal perspectives on future opportunities and trends that may bring us closer to the promise of functional ECPs.

Biomimetic Cardiac Microsystems for Pathophysiological Studies and Drug Screens

Engineering Cardiac Tissue for Advanced Heart‐on‐a‐chip Platforms

Cardiac Meets Skeletal: What’s New in Microfluidic Models for Muscle Tissue Engineering

Engineering a living cardiac pump on a chip using high-precision fabrication

Heart-on-a-chip systems with tissue-specific functionalities for physiological, pathological, and pharmacological studies

Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications

Fabrication and Biomedical Applications of Heart-on-a-chip

A microscale biomimetic platform for generation and electro-mechanical stimulation of 3D cardiac microtissues

Biofabrication strategies for cardiac tissue engineering

Recent developments in organ-on-a-chip technology for cardiovascular disease research

Organ-on-a-chip technology: a novel approach to investigate cardiovascular diseases

Engineered human cardiac tissues for modeling heart diseases

Organ-on-a-Chip Systems: Microengineering to Biomimic Living Systems.

Biosensors integrated 3D organoid/organ-on-a-chip system: A real-time biomechanical, biophysical, and biochemical monitoring and characterization

Recent advances on bioengineering approaches for fabrication of functional engineered cardiac pumps: A review

Design and fabrication of an integrated heart-on-a-chip platform for construction of cardiac tissue from human iPSC-derived cardiomyocytes and in situ evaluation of physiological function

Biohybrid Printing Approaches for Cardiac Pathophysiological Studies

Engineered platforms for mimicking cardiac development and drug screening

Micro‐Engineered Heart Tissues on‐Chip with Heterotypic Cell Composition Display Self‐Organization and Improved Cardiac Function

Engineering Three-Dimensional Cardiac Microtissues for Potential Drug Screening Applications.

Microfluidic Organ-on-a-Chip System for Disease Modeling and Drug Development